Screener
Protagonist Therapeutics PTGX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $7.88B.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's market capitalization?
- Protagonist Therapeutics (PTGX) reported market capitalization of $7.88B in Q2 2026.
- How has Protagonist Therapeutics's market capitalization changed year-over-year?
- Protagonist Therapeutics's market capitalization increased by 136.9% year-over-year, from $3.33B to $7.88B.
- What is the long-term trend for Protagonist Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's market capitalization has grown at a 41.5% compound annual growth rate (CAGR), from $962.2M to $5.46B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Protagonist Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude